diflunisal vs methotrexate
According to this portal's Publishing Organization, this page was last reviewed in August 2026 against our methodology. Figures and extracts on this site, including tables above 1,000 rows when the corpus is that large, are the publisher's responsibility.
Side-by-side comparison of diflunisal and methotrexate. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
moderate Known Drug Interaction
Methotrexate NSAIDs have been reported to competitively inhibit methotrexate accumulation in rabbit kidney slices. This may indicate that they could enhance the toxicity of methotrexate. Caution should be used when NSAIDs are administered concomitantly with methotrexate.
Dolobid
Trexall, Otrexup
Diflunisal is a medicine that can help with pain and swelling. It belongs to a class of drugs called NSAIDs.
Methotrexate is a drug that can treat certain cancers, rheumatoid arthritis, psoriasis, and other conditions. It works by slowing the growth of cells in the body.
Diflunisal can help with mild to moderate pain. It can also treat the symptoms of osteoarthritis and rheumatoid arthritis. You should use the lowest dose that works for you, for the shortest time needed.
Methotrexate can treat acute lymphoblastic leukemia, a type of cancer, in adults and children. It also treats mycosis fungoides, a skin lymphoma, in adults. Additionally, it treats relapsed or refractory non-Hodgkin lymphoma in adults. For non-cancer conditions, it treats rheumatoid arthritis in adults, polyarticular juvenile idiopathic arthritis (pJIA) in children, and severe psoriasis in adults.
Diflunisal reduces pain and swelling by blocking the production of certain chemicals in your body. These chemicals cause inflammation and pain. By blocking them, diflunisal helps to relieve your symptoms.
Methotrexate blocks an enzyme called dihydrofolate reductase. This enzyme is needed for cells to grow and multiply. By blocking this enzyme, methotrexate slows down the growth of cells, especially cancer cells and cells that cause inflammation in arthritis and psoriasis.
- • Nausea
- • Vomiting
- • Upset stomach
- • Stomach pain
- • Diarrhea
- • Mouth sores
- • Nausea
- • Abdominal pain
- • Changes in liver tests
- Nausea 66
- Fatigue 57
- Pain 50
- Drug Hypersensitivity 47
- Headache 45
- Rheumatoid Arthritis 38,053
- Arthralgia 36,283
- Pain 35,413
- Fatigue 29,061
- Nausea 24,009
NSAIDs like diflunisal can increase your risk of heart problems like heart attack and stroke, which can be deadly. This risk is higher if you take it for a long time. You should not take diflunisal if you are having heart bypass surgery. NSAIDs also raise your risk of serious stomach problems like bleeding and ulcers, which can also be deadly. Older adults are at higher risk for these stomach problems.
Methotrexate can cause serious harm to an unborn baby, including death. If you are pregnant, you should not take this medicine for non-cancer conditions. If you are taking it for cancer, talk to your doctor about the risks. This medicine can also cause severe allergic reactions and other serious side effects that can be life-threatening. Contact your doctor immediately if you experience any signs of infection, lung problems, or kidney problems.
Tell your doctor if you are pregnant or plan to become pregnant. Taking diflunisal late in pregnancy may harm your baby. It is not known if diflunisal passes into breast milk, so talk to your doctor before breastfeeding.
Methotrexate can cause birth defects or fetal death if taken during pregnancy for non-cancer conditions. If you are pregnant or plan to become pregnant, talk to your doctor. Do not breastfeed while taking methotrexate, as it can pass into breast milk and harm your baby.
Also Compare, Nearby Drugs
Compare diflunisal with
Compare methotrexate with
How to Read This diflunisal vs methotrexate Comparison
diflunisal is classified in the Nonsteroidal Anti-Inflammatory Drug (NSAID) drug class, while methotrexate sits within the Disease-Modifying Antirheumatic Drug (DMARD) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, diflunisal has 265 submissions while methotrexate has 162,819. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known moderate interaction flagged in FDA labeling, attributed to diflunisal can prevent your kidneys from clearing methotrexate out of your system, which can lead to toxic levels of the drug in your blood. this makes the side effects of methotrexate much more dangerous.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for diflunisal or methotrexate.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.